Blepharitis is one of the most common eye conditions there is, and one of the most under-treated. The good news: a simple daily routine can control it almost completely.
Blepharitis is a chronic inflammation of the eyelid margins, the thin strip of skin where the eyelashes grow. It causes redness, irritation, and crusting along the lash line, and it is remarkably common. Most people who have it have had it for years without knowing what it is called. It is not dangerous, it does not damage vision in most cases, and it cannot be cured outright. Plenty of patients find that last part frustrating to hear. But it responds very well to the right daily routine, and for most people that routine is simpler than they expect.
What You Need to Know About Blepharitis
- Blepharitis tends to come and go rather than resolve permanently with a single course of treatment Specialist management is provided by the cornea and refractive surgery subspecialty.
- It comes in two main forms: anterior blepharitis (affecting the outer lid margin and lash bases) and posterior blepharitis (affecting the meibomian oil glands inside the lid)
- Both forms are treated primarily with eyelid hygiene (assessed with eyelid photography): warm compresses (heat applied to the eyelid margin) (applying gentle heat , see the slit lamp page for how this is examined) and lid cleaning done consistently
- It is closely linked to dry eye disease, and the two conditions frequently occur together and make each other worse
- Rosacea and seborrhoeic dermatitis are common underlying skin conditions associated with blepharitis
- Antibiotics help during flares but lid hygiene is the long-term foundation of control
Anterior vs Posterior Blepharitis
Many people have both types simultaneously. Understanding which one drives your symptoms helps focus the treatment.
- Affects the outer lid margin and base of the lashes
- Causes crusting, flaking, and debris around the lashes
- Often linked to staphylococcal bacteria or seborrhoeic dermatitis
- Lashes may become misdirected or fall out in severe cases
- Treated with lid scrubs targeting the lash bases
- Antibiotic ointment at the lid margin during flares
- Affects the meibomian oil glands inside the lid margin
- Gland openings become blocked or produce thick, abnormal secretion
- Strongly associated with rosacea and meibomian gland dysfunction
- Disrupts the tear film and is a major cause of evaporative dry eye
- Treated with warm compresses (applying gentle heat , see the slit lamp page for how this is examined) to soften gland secretions
- Often requires omega-3 supplements and sometimes oral antibiotics
What Causes Blepharitis?
Bacteria and skin conditions
Anterior blepharitis is most commonly caused by an overgrowth of staphylococcal bacteria that normally live on the skin in small numbers. In people with blepharitis, these bacteria accumulate along the lid margin and produce toxins that irritate the delicate lid tissue. Seborrhoeic dermatitis, a skin condition that causes flaky, oily patches on the scalp and face, is closely associated and often makes blepharitis harder to control.
Demodex mites, microscopic organisms that live in hair follicles, have increasingly been recognised as a significant contributor in older patients and those whose blepharitis doesn’t respond well to standard treatment. Specialised in-office treatments targeting Demodex are now available in some clinics.
Meibomian gland dysfunction
Posterior blepharitis is fundamentally a disease of the meibomian glands, which produce the oily component of the tear film. When these glands become inflamed or blocked, the oil they produce changes in consistency, becoming thicker and more viscous. Abnormal oil plugs the gland openings, disrupts the tear film, and causes the evaporative dry eye symptoms that many patients notice first. Rosacea is strongly associated with meibomian gland dysfunction, and many patients who get recurrent chalazia have underlying posterior blepharitis driving the problem.
Symptoms
Blepharitis symptoms tend to be worse in the morning and improve as the day goes on. The most common complaints are:
- Gritty, burning, or scratchy sensation in the eyes, often worst on waking
- Redness along the lid margins
- Crusting or flaking around the base of the lashes, particularly in the morning
- Sticky or matted lashes on waking
- Eyes that water excessively despite feeling dry
- Temporary blurring of vision that clears with blinking
- Light sensitivity in more inflamed cases
Symptoms fluctuate. Most people have stretches of relative comfort followed by flares, often triggered by stress, illness, or environmental factors like air conditioning. The most useful shift in thinking about blepharitis is this: don’t wait for a flare. Start the routine and keep it going. The goal is regular maintenance that prevents flares from happening in the first place.
Treatment
No permanent cure, but blepharitis responds very well to a consistent daily routine. Think of it exactly like managing a skin condition: you don’t treat it once and stop. You manage it ongoing, and when you do it reliably, it largely stays quiet.
Warm compresses
Five to ten minutes on the closed eyelids. The heat softens thickened meibomian gland secretions and makes them easier to clear with the lid scrub that follows. A heated eye mask stays warm longer than a flannel, which cools quickly. Especially important for posterior blepharitis.
Lid scrubs
Immediately after the warm compress, clean the lid margins with a commercial lid wipe or a cotton bud dampened with diluted baby shampoo. Small back-and-forth strokes along the base of the lashes, eye closed. Once or twice daily. Consistency matters more than intensity here.
Lubricating eye drops
Blepharitis disrupts the tear film, so most patients benefit from preservative-free artificial tears used regularly throughout the day. Drops with a lipid or oil component are particularly useful for posterior blepharitis. They supplement the deficient tear film and reduce the gritty, burning sensation that gets worse as the day progresses.
Antibiotics and other treatments
During flares, topical antibiotic ointment along the lid margin reduces the bacterial load and calms inflammation. For posterior blepharitis with rosacea or significant meibomian gland dysfunction, a low-dose course of oral doxycycline often produces sustained improvement, working as much through its anti-inflammatory effect as its antibiotic one. Omega-3 supplements support meibomian gland function. In-office treatments including thermal pulsation (LipiFlow) and intense pulsed light (IPL) are increasingly used for gland dysfunction that doesn’t respond adequately to home care.
Blepharitis, Dry Eye, and Chalazia: The Connection
Blepharitis rarely exists in isolation. It sits at the center of a web of related conditions.
Dry eye disease and posterior blepharitis are so closely linked that many specialists treat them as two aspects of the same underlying problem. Blepharitis damages the meibomian glands that produce the oily layer of the tear film. Without that layer, tears evaporate too quickly, causing dry eye symptoms even when the eye is producing a normal volume of tears. Treating the blepharitis improves the dry eye; managing the dry eye reduces the irritation that makes blepharitis flares more likely.
Chalazia are a direct consequence of meibomian gland dysfunction caused by posterior blepharitis. People who get recurrent chalazia almost always have underlying blepharitis that hasn’t been adequately treated. Consistent lid hygiene is the most effective way to reduce how often chalazia come back.
Rosacea, the inflammatory skin condition affecting the face, is a common root cause of all three. Many patients see substantial improvement in both their skin and eye symptoms when the rosacea is treated properly by a dermatologist alongside the eye-directed treatments.
See Your Ophthalmologist If You Notice
- A painful red lump on the eyelid not resolving with warm compresses (applying gentle heat , see the slit lamp page for how this is examined)
- Significant loss of eyelashes or lashes growing in abnormal directions
- Redness and crusting that has got worse despite regular lid hygiene
- Any change in vision alongside an inflamed eyelid
- Signs that inflammation has spread beyond the lid margin
Most blepharitis is managed comfortably at home. But some flares become more severe and need professional attention. If your symptoms are a lot worse than usual, or new symptoms appear that you haven’t had before, get it looked at rather than just stepping up the hygiene routine and hoping it settles.
Frequently Asked Questions About Blepharitis
-
Will blepharitis ever go away completely?
For most people, no. Blepharitis is a long-term condition you manage rather than cure. With a consistent lid hygiene routine, symptoms can be so well controlled that many people go long stretches with no noticeable problems at all. Stopping the routine tends to let symptoms creep back. Think of it like brushing your teeth: you don’t stop because your teeth feel fine today.
-
Is blepharitis contagious?
No. Completely not contagious. It’s driven by your own skin bacteria and gland function. You didn’t catch it from anyone and you can’t give it to anyone. No special precautions needed with family members or partners.
-
Can I wear contact lenses with blepharitis?
Many people do, successfully. The contact lens clinic is full of people with blepharitis managing just fine. Lenses can become less comfortable during flares because the disrupted tear film makes deposits build up more quickly. Daily disposables tend to be better tolerated than reusable lenses. If symptoms are noticeably worse with lenses, switching to glasses until the flare settles usually helps a lot. Your optometrist can advise on the best lens type for your situation.
-
My eyes are watery, not dry. Could it still be blepharitis?
Almost certainly yes. When the tear film breaks down and the eye surface becomes irritated, the lacrimal gland produces a flood of watery reflex tears. The result is watery eyes that are paradoxically dry and uncomfortable. Patients find this very confusing. Treating the underlying blepharitis usually resolves the watering along with everything else.
-
How long before lid hygiene starts to help?
Most people notice some improvement within two to four weeks of consistent daily lid hygiene. Full benefit often takes six to eight weeks. The key is doing it every day, not only when symptoms flare. Many patients start when things are bad, feel better, stop — and then wonder why it came back three weeks later. Don’t be that patient. The routine needs to continue even when things feel comfortable.
-
Do I need antibiotics for blepharitis?
Not as a long-term solution. Antibiotics are useful during flares or when bacterial overgrowth is significant, but they treat the symptom, not the cause. Lid hygiene addresses the root problem by reducing bacterial load and improving meibomian gland function. Antibiotics alongside lid hygiene during a bad flare makes sense. Antibiotics alone, without the hygiene routine, doesn’t achieve lasting control.
If you would like to learn more, the American Academy of Ophthalmology’s blepharitis page offers a clear overview of symptoms, causes, and treatment options.
Blepharitis is a chronic, bilateral inflammatory condition of the eyelid margins, encompassing a spectrum from anterior eyelid margin inflammation (staphylococcal and seborrheic subtypes) to posterior lid margin disease driven by meibomian gland dysfunction (MGD). It is one of the most common conditions in ophthalmic practice, affecting approximately 37-47% of patients seen by ophthalmologists and optometrists, though its chronic course and incomplete treatment response make it one of the most frustrating to manage well. The anterior-posterior classification remains clinically useful for understanding mechanisms and guiding treatment, but most patients have overlap of both subtypes. Blepharitis is not curable , it is managed. Patient expectation-setting about this from the first visit avoids the cycle of escalating treatments and disappointed patients that characterizes poorly managed chronic blepharitis.
Clinical Overview: Blepharitis
- Classification: Anterior blepharitis , affects skin and lash follicles. Staphylococcal: collarettes at lash bases, misdirected lashes, lid ulceration, reactive papillary conjunctivitis. Seborrheic: waxy scales at lash roots, associated with seborrheic dermatitis. Posterior blepharitis (MGD) , meibomian gland obstruction, altered meibum quality, lid margin telangiectasia, evaporative DED.
- Demodex blepharitis: Demodex folliculorum (anterior) and Demodex brevis (sebaceous glands) are mites that colonize lid follicles and meibomian glands. Cylindrical dandruff (CD) , waxy collarettes encircling the lash at the follicle base , are pathognomonic for Demodex infestation. Prevalence increases with age; nearly universal over 70. Demodex triggers posterior blepharitis through MGD and anterior disease through follicular inflammation and exotoxins.
- Demodex treatment: Lotilaner 0.25% ophthalmic solution (Xdemvy) , licensed FDA 2023, 6 weeks twice daily; 80% Demodex elimination. Tea tree oil (TTO) 50% lid scrubs or 4% facial wash , effective but causes significant ocular surface irritation. Ivermectin systemic (200 µg/kg single dose, repeated at 7 days) for severe/refractory infestation.
- First-line lid hygiene: Warm compresses (40°C, 4-8 minutes) + lid margin cleansing (commercial lid wipes , Blephaclean, Lid-Care; diluted baby shampoo is inferior to purpose-made preparations). Twice daily initially, reducing to once daily for maintenance.
- Topical antibiotics: Chloramphenicol ointment or azithromycin 1% drops to lid margins for staphylococcal anterior blepharitis. Azithromycin has anti-inflammatory properties beyond antibacterial effect and penetrates meibomian glands.
- Systemic antibiotics: Doxycycline 50-100 mg daily for 6-12 weeks , indicated for moderate-severe posterior blepharitis/MGD, rosacea-associated blepharitis, or recurrent styes. Anti-inflammatory mechanism (MMP inhibition) is as important as antibacterial.
Pathophysiology
Anterior blepharitis , staphylococcal: Staphylococcus aureus and Staphylococcus epidermidis colonize the lid margin at higher concentrations in blepharitis than in healthy lids. Staphylococcal exotoxins (delta-toxin, alpha-toxin) cause direct epithelial damage, drive mast cell degranulation, and produce Type IV hypersensitivity reactions at the lash follicle. Collarettes , fibrinous exudate around the lash base , are characteristic. Chronic staphylococcal blepharitis produces lid margin scarring, lash loss (madarosis), lash misdirection (trichiasis), and inferior corneal pannus from chronic limbal inflammation (phlyctenulosis).
Posterior blepharitis , MGD: Hyperkeratinization of the meibomian gland duct orifice and increased meibum viscosity produce gland obstruction. Bacterial lipases from lid commensals (Staphylococcus, Cutibacterium acnes, Corynebacterium) degrade trapped meibum into toxic free fatty acids, which cause lid margin inflammation and evaporative tear film instability. This is the pathophysiological link between posterior blepharitis and dry eye disease , they co-exist in the majority of symptomatic cases.
Demodex: The two species colonize different niches. Demodex folliculorum inhabits the lash follicle and feeds on epithelial cells; it produces the cylindrical dandruff collarettes that are pathognomonic. Demodex brevis inhabits the meibomian and sebaceous glands, contributing to MGD. Both stimulate inflammatory cytokine release and carry bacteria on their cuticle , introducing organisms deeper into the lid margin than surface decontamination can reach. Demodex density above 5 per lash (or any in certain contexts) is considered clinically significant.
Examination and Diagnosis
Systematic slit-lamp lid margin examination: Upper and lower lids bilaterally at the slit lamp. Anterior lid margin: lash bases for collarettes (staphylococcal) or cylindrical dandruff (Demodex), lash condition (madarosis, trichiasis, poliosis), lid margin vascularity and irregularity. Posterior lid margin: meibomian gland orifice appearance (plugging, dropout, telangiectasia), meibum quality on digital expression or Meibomian Gland Evaluator. Tarsal conjunctiva: papillary reaction (staphylococcal hypersensitivity), follicular reaction (Demodex or viral), scarring (chronic disease). Cornea: inferior punctate epithelial erosions (chronic MGD), inferior marginal infiltrates (staphylococcal hypersensitivity), phlyctenules at limbus (advanced staphylococcal hypersensitivity), corneal pannus inferiorly.
Identifying cylindrical dandruff (Demodex): The pathognomonic waxy cylindrical sleeve at the lash base, encircling the lash like a cuff, is best seen at high magnification (×16-25) at the slit lamp. It is distinct from the fibrinous collarette of staphylococcal blepharitis (which sits at the lash root but does not form a cylindrical sleeve). Epilating a lash and examining under light microscopy shows adult Demodex mites and confirms infestation. In high-prevalence populations (elderly, rosacea, chronic blepharitis), treating for Demodex empirically without microscopy is reasonable if CD is visible.
Treatment in Detail
Lid hygiene , the foundation: All patients require warm compress and lid cleansing as the irreducible minimum. Compliance is the main failure mode , patients manage twice daily for a week, then stop. At each follow-up visit, review the hygiene technique. Heated eye masks (MGDRx EyeBag, Blephasteam goggle) are more consistently effective than DIY warm cloths. Commercial lid wipes (Blephaclean, Lid-Care) work better than diluted baby shampoo for the posterior lid margin. For patients who cannot manage daily lid scrubs, OptiLight or LipiFlow treatments reduce maintenance burden.
Topical antibiotics for anterior blepharitis: Azithromycin 1% ophthalmic solution applied to the lid margin twice daily for 2 days, then once daily for 28 days. Chloramphenicol 1% ointment to the lid margin at night (avoid long-term , aplastic anaemia risk, though rare with topical use). Fusidic acid for staphylococcal collarettes. Reserve topical antibiotics for acute exacerbations with significant lid margin inflammation , they are not for indefinite use.
Doxycycline: 50 mg daily (subantimicrobial dose for anti-inflammatory effect) or 100 mg daily for 6-12 weeks in rosacea-associated posterior blepharitis. Its MMP-inhibiting properties reduce meibum degradation by bacterial lipases and decrease ocular surface inflammation. Take with food (esophageal irritation risk). Avoid in pregnancy and in children under 8. Sun protection required (photosensitizing). Oxytetracycline 250 mg twice daily is the UK equivalent.
Demodex-specific treatment: Lotilaner 0.25% (Xdemvy), twice daily for 6 weeks, is the first FDA-approved treatment specifically for Demodex blepharitis. In-office tea tree oil 50% lid treatment (carried out in the clinic , too concentrated for self-use) is effective but causes significant irritation. 4% TTO face wash used at home reduces Demodex burden more gently. Ivermectin oral is reserved for severe infestations with significant systemic parasite burden or widespread rosacea.
Complications
Stye and chalazion: Acute staphylococcal folliculitis (hordeolum/stye) and chronic lipogranuloma of the meibomian gland (chalazion) are both complications of blepharitis, sharing the same infected and obstructed gland environment. Recurrent chalazia in a patient who is not performing adequate lid hygiene is a reliable indicator of undertreated posterior blepharitis.
Trichiasis and madarosis: Chronic anterior blepharitis causes lid margin scarring with inward-turned lashes (trichiasis , causes corneal abrasion and ulceration) and lash loss (madarosis). Trichiasis requires epilation, electrolysis, cryotherapy, or laser follicle ablation depending on extent. Note: madarosis from blepharitis must be distinguished from madarosis secondary to hypothyroidism or systemic disease.
Phlyctenulosis: Limbal or bulbar conjunctival phlyctenules , nodular staphylococcal hypersensitivity reactions , occur in patients with severe staphylococcal anterior blepharitis. They cause intense photophobia and localized injection. Treatment: topical corticosteroid plus lid hygiene intensification. Recurrent phlyctenulosis requires consideration of lid culture and systemic investigation for underlying immune dysregulation.
Clinical Decision Points
- Recurrent chalazia despite lid hygiene: Perform photographed at baseline; meibomian gland expression to assess meibum quality. If severely inspissated, add doxycycline 50 mg daily for 8 weeks. Consider thermal pulsation (LipiFlow) or IPL. Check for Demodex.
- Chronic blepharitis with DED refractory to lubricants: The posterior blepharitis component is driving evaporative DED. Intensify lid hygiene, treat MGD specifically (heated masks + expression), and add anti-inflammatory therapy (cyclosporine A, azithromycin to lid margin). DED will not resolve without addressing the meibomian gland disease.
- Cylindrical dandruff on slit-lamp examination: Treat for Demodex before other blepharitis treatments. Demodex infestation creates a reservoir of bacteria and inflammatory triggers that reduces the efficacy of standard blepharitis management. Offer lotilaner 0.25% (if available) or 4% TTO face wash.
- Severe staphylococcal blepharitis with phlyctenulosis and corneal pannus: This is sight-threatening in extent. Lid cultures, systemic exclusion of immune deficiency, topical corticosteroid with antibiotic cover, aggressive lid hygiene, and review at 2-4 weeks.
When to Escalate
- Corneal ulcer at the inferior limbus in a patient with known blepharitis , presumed marginal keratitis or microbial keratitis; requires scraping and urgent treatment
- Phlyctenule with progressive corneal involvement , sight-threatening corneal melt in severe staphylococcal hypersensitivity
- Unilateral madarosis, particularly if nodular lid lesion palpable , exclude sebaceous gland carcinoma (masquerades as chronic unilateral blepharitis)
Sebaceous gland carcinoma of the eyelid is a rare but life-threatening malignancy that classically masquerades as recurrent unilateral chalazion or unilateral blepharitis with loss of lashes. The key red flag is unilateral blepharitis with madarosis that does not respond to treatment, particularly in patients over 50. Any such presentation warrants a lid biopsy before attributing the lash loss to benign chronic inflammation.
Clinical Pearls: Blepharitis
-
Blepharitis is chronic and incurable. Every consultation should say so. Patients who know this make better long-term treatment decisions.
The single most common reason patients present repeatedly in blepharitis clinics having tried multiple treatments is that they believed blepharitis would be cured. When the first treatment helps but doesn’t resolve the problem, they seek a different or stronger treatment. When the second treatment does the same, they conclude they have an unusually severe case and need specialist referral. Most of these patients simply need clear communication at the start: blepharitis is a lifelong condition managed with maintenance therapy, not cured with a course of treatment. Lid hygiene is a daily habit, like tooth brushing, not a treatment to be stopped when things improve.
-
Demodex is underdiagnosed and undertreated because it requires deliberate slit-lamp assessment at high magnification.
Cylindrical dandruff is not visible unless you are specifically looking for it at ×16-25 magnification. It is routinely missed in a standard lid inspection. In any patient with chronic, recurrent, or treatment-refractory blepharitis , particularly in older adults, patients with rosacea, and anyone with recurrent styes , examine the lash bases specifically for CD before concluding the standard management has failed. Treating Demodex changes the management trajectory in a substantial proportion of these patients.
-
Rosacea-associated posterior blepharitis requires doxycycline and dermatology co-management, not just eye drops.
Ocular rosacea affects approximately 58% of patients with cutaneous rosacea and can precede the skin manifestations by years. The telangiectatic changes on the eyelid margin, the inspissated meibum, and the evaporative DED in rosacea are driven by the same MMP-mediated inflammatory process affecting the skin. Topical eye treatments alone are inadequate for rosacea-associated posterior blepharitis , doxycycline (or oxytetracycline) for its systemic anti-inflammatory effect is the cornerstone. Dermatology co-management for skin rosacea control benefits the eye disease as well.
Further reading: Blepharitis patient resources. For related ocular surface conditions see dry eye disease (strongly associated with MGD) and chalazion (a direct complication). The ocular surface context is covered on the cornea and refractive surgery subspecialty page.